Skip to content

Comparison Adequacy of Block with Different Doses of Intrathecal Lidocaine in Lower Extremity Amputation Surgery in Diabetic Foot Ulcers

Comparison Adequacy of Block with Different Doses Of Intrathecal Lidocaine in Lower Extremity Amputation Surgery in Diabetic Foot Ulcers

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190222042804N1
Enrollment
90
Registered
2019-10-14
Start date
2019-08-23
Completion date
Unknown
Last updated
2019-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic foot ulcers. Unspecified diabetes mellitus with unspecified complications

Interventions

Intervention 1: Intervention group (1): Patients are received intrathecal 30 mg lidocaine 1%. Intervention 2: Intervention group (2): Patients are received intrathecal 50 mg lidocaine 1%.

Sponsors

Ahvaz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: Age group 40 to 70 years Blood glucose higher than 80 and less than 250 Cardiac output higher than 20% American Society of Anesthesiologists (ASA) classification I, II

Exclusion criteria

Exclusion criteria: Patients with sepsis or coagulopathy Dissatisfaction to participate in the study

Design outcomes

Primary

MeasureTime frame
The time of onset of sensory block. Timepoint: Every 3 minutes after spinal anesthesia. Method of measurement: Pinprick test.;Sensory block duration. Timepoint: Every 10 minutes after the patient enters the recovery room. Method of measurement: Pinprick test.;The time of onset of motor block. Timepoint: Every 5 minutes after spinal anesthesia. Method of measurement: Three-point scale test.;Motor block duration. Timepoint: Every 10 minutes after the patient enters the recovery room. Method of measurement: Three-point scale test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHojatollah Ghanadi

Ahvaz University of Medical Sciences

Hojat.ghanadi@gmail.com+98 61 3333 5935

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026